Target intelligence / Profile preview

Immune system stimulation via presentation of viral antigens leading to adaptive immune response against Newcastle disease virus

Molecular classification
Other, Immune process, Not a single molecule, but involves major histocompatibility complex (MHC) molecules and antigen-presenting cells
01

Overview

The process involves the presentation of viral antigens from Newcastle disease virus by antigen-presenting cells (such as dendritic cells, macrophages, and B cells) to T lymphocytes, leading to the stimulation of adaptive immune responses. This includes the activation and differentiation of B and T lymphocytes, production of virus-specific antibodies, and generation of memory immune cells, which are essential for long-term immunity and effective vaccine responses against NDV. Various pattern recognition receptors, especially toll-like receptors (TLRs), play roles in the initial detection and activation steps. The quality and magnitude of the adaptive immune response can vary based on host genetics, viral strain, and environmental factors.

Other names
Antigen presentation pathwayImmune system activation by NDVAdaptive immune response to Newcastle disease virusViral antigen presentation
02

Mechanism of action

Presentation of NDV viral antigens by antigen-presenting cells (dendritic cells, macrophages, B cells) leads to activation of CD4+ and CD8+ T lymphocytes, stimulation of B cells to produce virus-specific antibodies, and induction of memory lymphocyte formation.

03

Biological functions

Immune responseAntigen presentationActivation of adaptive immunityInduction of humoral and cellular immunity
04

Disease associations

InfectionVaccine responseViral immunopathology
05

Safety considerations

Risk of vaccine-induced adverse effects (rare)Potential for immune overactivation in some settingsDifferences in host genetics can lead to variable vaccine efficacy or immune responses
06

Interacting drugs

Vaccines (e.g., live attenuated Newcastle disease virus vaccines)

2 more in the full profile.

07

Biomarkers

NDV-specific antibody titersT cell activation markers (e.g., CD69, CD25 on lymphocytes)Cytokine levels (e.g., interferon-gamma)Expression of MHC moleculesInterferon-stimulated gene expression

Beyond the preview

Go deeper on Immune system stimulation via presentation of viral antigens leading to adaptive immune response against Newcastle disease virus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system stimulation via presentation of viral antigens leading to adaptive immune response against Newcastle disease virus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call